Bulk Drugs Segment Of Indian Pharma Sector To See 6-8% Growth In FY24
The bulk drugs segment of the Indian pharmaceutical sector is expected to see revenue grow at 6 to 8 per cent this fiscal year, helped by higher sales volume stemming from a stable growth outlook, according to a Crisil Ratings report. The bulk drug segment posted 8-10 per cent revenue growth last fiscal, mainly because […]